KOSDAQOthers119830

Itek

₩6,490▼ 6.21%2026-10-02 close
Market Cap
₩172B
Turnover
₩1.4B
Volume
200,000 shares
Shares out.
26.5M
PER
—
PBR
0.8×
EPS
-₩370
Dividend Yield
0.00%

PER, EPS, PBR and BPS are calculated in-house from the last 4 quarters (2025Q3–2026Q2) · Dividend yield is based on ₩0 per share · Prices as of the 2026-10-02 close

01

Report overview

Test Business Shows Recovery Signs Amid Earnings Volatility

ITEK is a diversified company centered on semiconductor testing alongside cosmetics, pharmaceuticals, graphene, and battery safety management businesses; operating profit turned positive in the second quarter of 2026, but large swings in non-operating items have repeatedly changed the direction of recent quarterly results.

  1. 1

    Semiconductor testing accounts for a significant portion of revenue, alongside unrelated diversification businesses such as cosmetics and pharmaceuticals.

  2. 2

    In May 2026 the company obtained bonded-zone status from Suwon Customs, allowing overseas wafer and package products to be fed directly into testing without import declaration.

  3. 3

    Consolidated revenue declined for three consecutive years from 2023 to 2025, while the scale of operating losses gradually narrowed.

  4. 4

    Quarterly net income attributable to owners has swung widely independent of operating profit, showing the strong influence of non-operating items.

  5. 5

    The company is diversifying its customer portfolio toward AI and autonomous-driving semiconductor testing, including a partnership with a domestic on-device AI chip firm.

02

Business structure

Founded in 2005, ITEK is a system semiconductor test specialist operating as an OSAT (back-end) test house that performs final pass/fail determination after package assembly.

Its main customers are IDM and fabless companies that outsource semiconductor testing, and the company serves overseas clients through sales offices in the United States, Taiwan, and Japan in addition to its domestic base.

According to a May 2025 Hana Securities report, the company had secured more than 176 customers at that time.

Beyond semiconductor testing, disclosures show the company also operates in cosmetics manufacturing and sales, pharmaceutical wholesale and distribution, graphene-related product manufacturing and distribution, cold-chain terminals and solutions, digital signage and robot integrated control solutions, and battery safety management systems.

According to older disclosure data (as of the first half of 2023), semiconductor testing accounted for about 50.3% of revenue, cosmetics 20.1%, and pharmaceuticals 18.5%, illustrating a highly diversified business mix.

The graphene business is conducted through a roughly 30.23% equity stake in a graphene composite material company founded in 2017.

More recently, the company has expanded into high-specification testing for AI and autonomous-driving semiconductors and is reported to serve as a test partner for a domestic on-device AI chip firm named DeepX.

In May 2026, the company obtained bonded-zone status from Suwon Customs, enabling wafers and package products imported from overseas to be fed directly into the test line without import declaration.

03

Earnings trend

Quarterly revenue · Operating profit
RevenueOperating profit
Annual revenue · Operating profit
RevenueOperating profit
Quarterly results · Last 5 quarters
QuarterRevenueOperating profitOp. margin
2025Q2₩15.5B-₩1.6B−10.0%
2025Q3₩14.3B-₩400M−2.6%
2025Q4₩4.8B₩3.3B67.7%
2026Q1₩12.1B-₩300M−2.4%
2026Q2₩14.2B₩1.1B7.6%
Annual results
YearRevenueOperating profitNet income (parent)Op. marginROEDebt-to-equity
2022₩76.7B₩700M₩21.7B0.9%15.4%26.3%
2023₩83.3B-₩7.2B-₩7.4B−8.6%−5.1%49.6%
2024₩62B-₩4.9B₩20B−7.9%12.1%36.3%
2025₩48.5B-₩300M-₩4.6B−0.5%−2.7%22.4%

Consolidated basis (financial statements including subsidiaries) · Final figures from DART filings · Net income attributable to owners of the parent · Data as of 2026-08-21

04

Earnings analysis

Consolidated revenue rose from KRW 76.65 billion in 2022 to KRW 83.26 billion in 2023, but then declined for three consecutive years to KRW 61.96 billion in 2024 and KRW 48.52 billion in 2025, a substantial contraction in scale.

Operating profit was positive at KRW 0.72 billion in 2022 before turning to losses of KRW -7.18 billion in 2023 and KRW -4.87 billion in 2024, then narrowing to KRW -0.26 billion in 2025, a trajectory approaching break-even.

Net income attributable to owners followed a different path, swinging from a KRW 21.66 billion profit in 2022 to a KRW -7.41 billion loss in 2023, back to a KRW 20.01 billion profit in 2024, and then a KRW -4.64 billion loss in 2025.

This influence of non-operating items is even more pronounced at the quarterly level: in the fourth quarter of 2025, operating profit improved sharply to KRW 3.27 billion, yet net income attributable to owners posted a loss of KRW -4.92 billion, and in the first quarter of 2026, an operating loss of only KRW -0.30 billion coincided with a net loss that widened to KRW -8.28 billion.

In the second quarter of 2026, all three metrics improved together, with revenue of KRW 14.25 billion, operating profit of KRW 1.08 billion, and net income attributable to owners of KRW 2.78 billion.

Over the trailing four quarters (third quarter of 2025 through second quarter of 2026), cumulative net income attributable to owners totaled a loss of KRW -9.77 billion, reflecting significant earnings volatility over the past year.

Operating cash flow actually improved to KRW 18.76 billion in 2025 despite the net loss, a stronger figure than the KRW 12.77 billion in 2024, KRW -5.93 billion in 2023, and KRW 11.15 billion in 2022, suggesting a divergence between accounting profit and actual cash generation.

05

Industry analysis

One report projected that the global semiconductor market in 2026 would reach about USD 909.8 billion, up roughly 17.8% year over year, with advancing AI technology and the commercialization of autonomous driving cited as key demand drivers.

In the system semiconductor test industry, an increasing trend toward diversified, low-volume production is said to raise the importance of customized responses, which analysts suggest will increase the need for specialized outsourced test providers.

Hana Securities analyzed that AI and autonomous-driving semiconductors, which require high specifications and stability, take longer to test due to higher difficulty, which raises average selling prices, and noted its view that the number of semiconductors installed in autonomous vehicles could increase more than tenfold compared to conventional vehicles.

Companies cited as operating in similar businesses include DI Corporation, ALT, Posfil, and JH Cos. Regarding the battery safety management systems segment, one view suggested demand could increase alongside ESS market growth and the expansion of renewable energy.

That said, demand for legacy and mobile-centered semiconductor testing can be volatile during memory industry downturns as customers adjust inventory levels.

06

Outlook

Following its designation as a bonded zone by Suwon Customs in May 2026, the company built a system that allows wafers and package products from overseas fabless customers to be tested immediately without import declaration, which management said would help reduce logistics costs and shorten turnaround time to support global customer expansion.

In a June 2026 report, GL Research analyzed that the company serves as a test partner for domestic on-device AI chip firm DeepX, and that the possibility of new AI NPU-based demand has been highlighted following DeepX's mass-production agreement with Taiwan's Aeon.

The same report also noted that the company is expanding cooperation with Samsung Foundry SAFE partner companies. In an investor relations session, the company stated it plans to gradually expand burn-in test equipment in response to growing demand for automotive (autonomous-driving) semiconductors.

It also explained that AI semiconductors typically take three to four years from development to mass production, and that it expects full-scale production to begin from 2026 onward.

Valuefinder Research stated its assessment that the company is accumulating NPU-related test references while also focusing on next-generation business expansion into physical AI and humanoid robots.

07

Valuation

PER
—
PBR
0.8×
ROE
-5.4%
EPS
-₩370
BPS
₩7,561
Dividend per share
₩0

The price-to-book ratio has traded at a discount to net asset value, which can be interpreted in light of the alternating profits and losses of recent years and the large quarter-to-quarter swings in non-operating items.

During periods when net income was negative, a price-to-earnings ratio could not be meaningfully calculated, and even incorporating the trailing four quarters, results remain in loss territory.

As for dividends, there has been no payout recorded for the most recent fiscal year, making yield-based comparisons of limited relevance.

The recurring pattern of alternating annual profits and losses from 2022 through 2025 appears to be reflected in valuation, and the company's diverse mix of unrelated businesses beyond semiconductor testing—including cosmetics, pharmaceuticals, and graphene—limits straightforward comparison with pure-play semiconductor test peers.

PER, EPS, PBR and BPS are all calculated in-house (the same method as Naver and Toss) · Dividend yield = cash dividend per share from DART filings (supplemented by KRX) ÷ current price · As of 2026-08-21

08

Bull factors

Signs of recovery in the semiconductor test segment

Operating profit and net income attributable to owners were both positive in the second quarter of 2026, marking an improvement in the earnings trend.

GL Research analyzed that utilization is recovering on rising demand for AI and automotive semiconductor testing, with a rising average selling price effect from a higher share of high-specification chips. Hana Securities similarly viewed that rising test difficulty could translate into higher selling prices.

Bonded-zone status strengthens logistics competitiveness

In May 2026, the company obtained bonded-zone status from Suwon Customs, allowing overseas wafer and package products to be fed directly into testing without import declaration.

This enables shorter turnaround times and cost savings from tariff deferral, with some assessments suggesting it provides a logistics advantage versus global OSAT competitors.

Expansion potential in AI and robotics

The company participates as a test partner for domestic on-device AI chip maker DeepX, and DeepX's mass-production agreement with Taiwan's Aeon has highlighted potential demand growth.

Expanded cooperation with Samsung Foundry SAFE partners and possible expansion into physical AI and humanoid robotics have also been mentioned.

09

Bear factors

Revenue decline for three consecutive years

Consolidated revenue fell for three consecutive years, from KRW 83.26 billion in 2023 to KRW 61.96 billion in 2024 and KRW 48.52 billion in 2025, a substantial contraction in business scale. Without a confirmed revenue recovery, profitability improvement in the fixed-cost-heavy testing business could remain limited.

Difficulty forecasting results due to non-operating items

In both the fourth quarter of 2025 and the first quarter of 2026, operating profit and net income attributable to owners moved in opposite directions due to large non-operating items. This volatility makes it difficult to forecast the future earnings trajectory.

Uncertain profitability of diversified businesses

Beyond semiconductor testing, unrelated businesses such as cosmetics, pharmaceuticals, and graphene appear to account for a meaningful share of revenue, but their individual profitability contributions are difficult to verify externally in detail. Operating multiple unrelated businesses simultaneously can increase the complexity of resource allocation.

10

Risk factors

Earnings volatility risk

Recent quarterly results repeatedly show operating profit and net income attributable to owners moving in opposite directions, confirming the significant influence of non-operating items.

Non-operating factors such as derivative valuations related to convertible bonds or investment asset valuation gains and losses could continue to sway results significantly.

Semiconductor cycle risk

Demand for legacy and mobile-centered testing can contract during memory industry downturns as customers adjust inventories. While the share of AI and autonomous-driving semiconductors is expanding, their precise contribution to total revenue has not been clearly confirmed.

Business diversification and capital structure risk

Simultaneously operating multiple businesses unrelated to semiconductor testing can strain management focus and resource allocation.

A history of equity investment in a graphene-related affiliate and convertible bond issuances also leaves open the possibility of future share dilution or changes in the financial structure.

11

What to watch next

  1. Mid-November 2026

    The third-quarter 2026 report is due to be disclosed around this time, offering a chance to check whether AI and autonomous-driving semiconductor test demand recovery continues and whether non-operating earnings volatility eases.

  2. Second half of 2026 through early 2027

    It will be worth checking whether actual test volumes materialize from DeepX's mass-production agreement with Taiwan's Aeon, along with any disclosures of new customer contracts.

  3. March 2027

    This is when the audit report and annual general meeting disclosures for fiscal year 2026 are expected, allowing confirmation of finalized annual results and the specific details of non-operating items.

  4. Timing of disclosures on bonded-zone utilization results

    It will be important to continue monitoring whether the company discloses actual overseas customer acquisitions and logistics cost savings resulting from its bonded-zone designation.

  5. Timing of any convertible bond-related disclosures

    If disclosures related to conversion requests or maturity occur, it will be necessary to check for potential changes in share count and financial structure.

12

Overall view

ITEK is a KOSDAQ-listed company with a diversified business portfolio centered on semiconductor testing alongside cosmetics, pharmaceuticals, graphene, and battery safety management.

Annual revenue declined for three consecutive years from 2023 through 2025, though the scale of operating losses gradually narrowed, and in the second quarter of 2026 both operating profit and net income attributable to owners turned positive simultaneously.

However, quarterly operating profit and net income have repeatedly moved in opposite directions, leaving non-operating earnings volatility as an important variable in interpreting results.

The May 2026 bonded-zone designation, expansion into AI and autonomous-driving semiconductor testing, and a partnership with a domestic on-device AI chip firm are cited as positive business momentum.

Conversely, the three-year revenue decline, uncertainty over the profitability of the diversified business structure, and the difficulty of forecasting results due to non-operating items warrant attention.

Before making any investment decision, it would be useful to monitor upcoming quarterly results, the practical outcomes of the bonded-zone status, and disclosures related to new contracts.

13

Sources

  1. Korea Exchange (KRX) — Prices · Market Cap · Volume
  2. FSS electronic disclosure system (DART) — Financial statements · Dividend filings
Show 18 more articles and sources
  1. markets.hankyung.com
  2. thevc.kr
  3. kr.investing.com
  4. m.thinkpool.com
  5. finance.biggo.com
  6. goinsider.kr
  7. fintel.io
  8. finance.biggo.com
  9. infostock.co.kr
  10. comp.fnguide.com
  11. comp.fnguide.com
  12. kind.krx.co.kr
  13. investing.com
  14. etoday.co.kr
  15. mt.co.kr
  16. core.asiae.co.kr
  17. cstimes.com
  18. theinvest.co.kr

Report written 2026-09-05 · Data as of 2026-09-04

This content is AI analysis of market data and web search results, provided for information only. It is not a solicitation or recommendation to invest. Investment decisions and their consequences are the investor's own responsibility. Data may be delayed or contain errors.